Merge Talks Between The EVERY Co and Onego Bio
The EVERY Co and Onego Bio were discussing a $400m merger before talks broke down, according to court documents.
Alt-egg startups The EVERY Company and Onego Bio had planned to create a new company with a valuation of $400m.
Patent Dispute
The EVERY Co is urging a court in Wisconsin to dismiss a lawsuit from Onego Bio seeking to invalidate one of EVERY's patents.
The patent in question covers the production of ovalbumin, the primary protein in egg white, via precision fermentation.
- The EVERY Co uses yeast (Komagataella phaffii) as its host microorganism.
- Onego Bio uses fungus (Trichoderma reesei).
The dispute centers on whether Onego is infringing a “foundational” patent (‘784) from The EVERY Co covering ovalbumin expression in a range of hosts.
Author's summary: Merger talks between The EVERY Co and Onego Bio failed, leading to a patent dispute.
More News
- Draymond Green Calls Out 'Terrible' Warriors After Shocking Loss to Giannis-Less Bucks
- Sabrina Carpenter ‘Arrests’ Corey Fogelmanis In 'Girl Meets World' Reunion
- Bam Adebayo's evolution into 'three-level scorer' starts with Heat's new offense
- Flyers flying under the radar — and deserve a packed house again | NorthPennNow
- A new AI technique may aid violent crime forensics
- Celebrity-approved Halloween nail ideas for spooky season – Scratch
- Post-Profit Antitrust | Yale Law Journal
- Forget monsters. The Blue Jays and Mother Nature are coming for you this Halloween | RCI
- Philadelphia Eagles QB Jalen Hurts Dressed As God For Halloween
- 'Love Island's' Huda Mustafa Apologizes After Laughing At Racist Slur Hurled Towards Olandria Carthen